Mast cell involvement in fibrodysplasia ossificans progressiva

Human Pathology

Volumn 32, Issue 8, 2001, Pages 842-848

  Gannon, Francis H ^a   Glaser, David ^a   Caron, Robert ^a   Thompson, Lester D R ^a   Shore, Eileen M ^a   Kaplan, Frederick S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fibrodysplasia ossificans progressiva; Heterotopic ossification; Mast cells; Osteogenesis

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4;

ARTICLE; CELL ACTIVATION; CELL FUNCTION; DISEASE ACTIVITY; FEMALE; GENETIC DISORDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAST CELL; MUSCLE BIOPSY; OSSIFYING MYOSITIS; PATHOGENESIS;

EID: 0034878150     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.26464     Document Type: Article

References (52)

1. Fibrodysplasia ossificans progressiva: A clue from the fly?
2. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients
3. Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients
4. Permanent heterotopic ossification at the injection site after diphtheria-tetanuspertussis immunizations in children who have fibrodysplasia ossificans progressiva
5. Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva
6. Acute lymphocytic infiltration in extremely early lesions of fibrodysplasia ossificans progressiva
7. The histopathology of fibrodysplasia ossificans progressiva. An endochondral process
8. Limb swelling in patients who have fibrodysplasia ossificans progressiva
9. Radiographic and scintigraphic features of modeling and remodeling in the heterotopic skeleton of patients who have fibrodysplasia ossificans progressiva
10. Spinal deformity in patients who have fibrodysplasia ossificans progressiva
11. Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva
12. Submandibular swelling in patients who have fibrodysplasia ossificans progressiva: A life threatening complication
13. Fibrodysplasia ossificans progressiva: Searching for the skeleton key
14. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva
15. Bone morphogenetic protein (BMP) 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva
16. Characterization of bone morphogenetic protein-4 receptors in fibrodysplasia ossificans progressiva
17. Protein builds second skeleton
18. Urinary basic fibroblast growth factor: A biochemical marker for pre-osseous fibroproliferative lesions in patients who have fibrodysplasia ossificans progressiva
19. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells
20. Factors inducing mast cell accumulation in skeletal muscle
21. Mast cells and basophils
22. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population
23. Stem cell factor induces mast cell adhesion to fibronectin
24. Murine mast cells synthesize basement membrane components. A potential role in early fibrosis
25. Mast cells
26. Contemporary issues in mast cell biology
27. Interaction of mast cells with extracellular matrix proteins
28. New concepts about the mast cell
29. Quantitative morphology of mast cells in skeletal muscle of normal and genetically dystrophic mice
30. Mast cells in neuromuscular diseases
31. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor
32. Heparin is essential for the storage of specific granule proteases in mast cells
33. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF206
34. Angiogenic and inflammatory responses following skeletal muscle injury are altered by immune neutralization of endogenous basic fibroblast growth factor, insulin-like growth factor-1 and transforming growth factor-beta 1
35. Human mast cell migration in response to members of the transforming growth factor-beta family
36. Molecular and cellular biology of mast cells and basophils
37. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: Demonstration of elevated levels in patients with disorders of systemic mast cell activation
38. Human mast cells activate fibroblasts: Tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis
39. Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumor tissue
40. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
41. The mast cell and bone
42. Recruitment of mast cells to muscle after mild damage
43. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
44. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice
45. Analysis of the effect of mast cell granules on lymphocyte blastogenesis in the absence and presence of mitogens: Identification of heparin as a granule-associated suppressor factor
46. Mast cell-T cell interactions
47. In vitro and in vivo immunostimulatory potential of bone marrow-derived mast cells on B- and T-lymphocyte activation
48. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact
49. Characterization of the earliest stages of post-natal endochondral ossification
50. Mast cells in fracture healing: An experimental study using rat model
51. Therapeutic strategies for allergic diseases
52. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: In vitro and in vivo evidence in murine systems